Statement Of Income

K Pharma,Inc. - Filing #7311570

Concept 2024-01-01 to
2024-06-30
2023-01-01 to
2023-06-30
Statement of income
Statement of income
Net sales
Net sales
JPY
1,000,000,000 JPY
Operating revenue
Operating expenses
Operating expenses - general
Remuneration for directors (and other officers)
51,600,000 JPY
36,200,000 JPY
Taxes and dues
468,000 JPY
24,094,000 JPY
Cost of sales
Cost of sales
JPY
90,000,000 JPY
Operating expenses
Selling, general and administrative expenses
423,489,000 JPY
258,890,000 JPY
Operating expenses
Research and development expenses
236,790,000 JPY
106,710,000 JPY
Ordinary profit (loss)
-422,670,000 JPY
651,026,000 JPY
Gross profit (loss)
JPY
910,000,000 JPY
Operating profit (loss)
-423,489,000 JPY
651,109,000 JPY
Non-operating income
Interest income
14,000 JPY
7,000 JPY
General and administrative expenses
Salaries
Gross profit
Selling, general and administrative expenses
Non-operating income
Non-operating income
819,000 JPY
7,000 JPY
Financial revenue
Non-operating expenses
Non-operating expenses
JPY
90,000 JPY
Extraordinary losses
2,677,000 JPY
36,497,000 JPY
Impairment losses
2,677,000 JPY
36,497,000 JPY
Profit (loss) before income taxes
-425,347,000 JPY
614,528,000 JPY
Income taxes - current
1,157,000 JPY
99,755,000 JPY
Extraordinary losses
General and administrative expenses
Income taxes
1,157,000 JPY
99,755,000 JPY
Profit (loss)
-426,505,000 JPY
514,772,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.